Sort
48,018 grants matching “immunotherapy”
Targeting Blys/Baff in non-human primate islet transplantation
$700,472Ali Naji · University Of Pennsylvania · U01 · FY2012 · AI
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
$700,470Miriam Merad · Icahn School Of Medicine At Mount Sinai · R01 · FY2021 · CA
Monoclonal antibody-based intervention against SIV in nonhuman primates
$700,369Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Systems-level identification of key regulators deciding immune cell state
$700,299Wei Wang · University Of California, San Diego · R01 · FY2023 · AI
Systems-level identification of key regulators deciding immune cell state
$700,299Wei Wang · University Of California, San Diego · R01 · FY2024 · AI
Dendritic cells heterogeneity and function
$700,270Roxane Tussiwand · National Institute Of Dental & Craniofacial Research · ZIA · FY2019 · DE
In vivo engineering of B cells for the secretion of HIV broadly neutralizing antibodies
$700,174James Even Voss · Scripps Research Institute, The · R01 · FY2025 · AI
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
$700,147Diane M Simeone · New York University School Of Medicine · R01 · FY2020 · CA
Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancer
$700,037Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DE
A robust platform for multiplexed, subcellular proteomic imaging in human tissue
$700,000Robert Michael Angelo · Stanford University · UH3 · FY2020 · CA
Novel Interventions Against HPV-associated Neoplasia
$699,960Paul F Lambert · University Of Wisconsin-Madison · U01 · FY2013 · CA
Enhancing Dendritic Cell Migration to Draining Sentinel Nodes to Improve Immunotherapy Response in HPV negative HNSCC
$699,929Joseph A Califano · University Of California, San Diego · R01 · FY2025 · CA
Resident Memory T Cells
$699,919David Masopust · University Of Minnesota · R01 · FY2025 · AI
Antibody dependent cellular cytotoxicity and HIV-1 mother to child transmission
$699,829Manish Sagar · Boston Medical Center · R01 · FY2022 · AI
Systems-level identification of key regulators deciding immune cell state
$699,745Wei Wang · University Of California, San Diego · R01 · FY2021 · AI
Enhancing the efficacy of immunotherapy in DLBCL using rational combination approaches
$699,639Cheryl A London · Tufts University Boston · U01 · FY2020 · CA
Spatial genomic tools to interrogate T cell clonotypes, tumor clones and the microenvironment
$699,616Fei Chen · Broad Institute, Inc. · R01 · FY2025 · CA
The Antigen Targeting Core
$699,594Maria Parkhurst · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Personalized vaccine for patients with AML
$699,542David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2019 · CA
Understanding IDH mutant gliomas
$699,386Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Laboratory and Clinical studies on T-cells recognizing NSCLC
$699,349James C Yang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Theranostic DLL3/PSMA-bi-specific CAR-T cells for prostate cancer therapy
$699,311Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Depleting exosomes to improve responses to immune therapy in HNSCC
$699,220Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · DE
Population Modeling of Bladder Cancer Detection and Control
$699,128Thomas Trikalinos · Brown University · U01 · FY2025 · CA
(8) Genetics of Immune Related Adverse Events and Response to Immunotherapy
$699,062Elad Ziv · University Of California, San Francisco · R01 · FY2018 · CA